We have been investigating the synthesis and biological properties of 6-hydroxyethyl carbapenem compounds1~4) and demonstrated that meropenem (MEPM, la in Fig. 
pounds1~4) and demonstrated that meropenem (MEPM, la in Fig. 1 ) having a ljS-methyl group and the 5'-dimethylammocarbonylpyrrolidin-3'-ylthio (DMAP) group exhibits an extended antimicrobial spectrum including anti-pseudomonal activity and high stability to renal dehydropeptidase-I (DHP-I)1}. From the structureactivity relationship studies, we found that the basicity of the C-2 side chain is important for exhibiting antimicrobial activity especially against Pseudomonas aeruginosa by supporting good permeability through the outer membrane(OM)5). However, the strength of the basicity does not directly correlate with the antipseudomonal activity5).
We also found that the Ifimethyl group of carbapenem compoundsnot only improves their DHP-I stability, but also variably affects their antimicrobial activity1 '5'6) . Regarding the effect of C-6 substituent, there are several studies on natural occurring or synthesized carbapenems which have a different substituent on C-6 from thienamycin (i.e., hydroxyethyl group)7~11}.
Stereochemical properties of the C-6 substituent have also been investigated with naturally occurring products, such as epithienamycins12).
Trans configuration of the /Mactam ring and the^-absolute configuration of the 8-hydroxyl group appears to be preferred for the antimicrobial activity and stability against /Mactamases and DHP-I12). However, there are no reports investigating the systematic structure-activity relationships between the antimicrobial activity and the C-6 substituent. On the basis of these studies, we investigated the effect of C-6 substituent, focusing on 5,6-trans ljS-methyl carbapenems, on the antimicrobial activity and the stability against DHP-I. In terms of activity against P. aeruginosa, not only the affinities of antimicrobial agents to the targets, penicillin binding proteins (PBPs), but also the permeability through the OMinfluence their effectiveness1 3). Therefore, we determined the affinity of carbapenem compounds for the PBPs of P. aeruginosa, expecting this would lead to additional information concerning permeability through the OMof the tested compounds. 
Chemistry
The carbapenem compounds were prepared in our laboratories by applying the Dieckmann-type cyclization method reported previously14 The MICs were measured by a twofold agar dilution method1^P. aeruginosa cell membraneswere prepared, and the affinities of the carbapenems for PBPs were determined by means of a competition assay using [14C] benzylpenicillin as described previously22). Since the PBPs la/lb, 2, and 3 of P. aeruginosa were reported as the targets of the /Mactarn antibiotics23), affinities for these PBPs are listed in the tables. The DHP-I stability was determined by a spectrophotometric method using partially purified DHP-I from swine kidney1}. The results were expressed as relative to MEPM (la) in terms of time required for hydrolysis of the compound to 80%
of initial.
To demonstrate the effect of lipophilicity and bulkiness of the C-6 substituent on the antimicrobial activity and the susceptibility to hydrolysis by DHP-I, l/?-methyl carbapenem compounds having four types of C-6 sub- (3), and (l-hydroxy)isopropyl (4) groups, were studied, and the results are listed in Table 1 . In addition, to clarify whether or not the effect of C-6 substituent is variable depending on the C-2 side chain, a series of compounds (1~4) having three types of the C-2 side chains (a~c) were investigated.
First was a DMAPgroup (a) as a weakly basic (pATa 7.4) side chain and one of the most potent side chains in 6-hydroxyethyl l/?-methyl carbapenemsx\ Second was a piperidinylthio group (b) as a basic side chain, and last was an 7V-acetylated derivative of the piperidinyl group (c) as a neutralized side chain. The 6-ethyl compound (2a) was still active against most organisms, but its antimicrobial activity was lower than that of 6-hydroxyethyl compound (la, MEPM). The antimicrobial activity of 6-isopropyl compound (3a) , in which the 8-hydroxyl group was substituted by a methyl group, was apparently decreased compared to 2a. The introduction of an additional methyl group to the 6-hydroxyethyl group (4a) showed a more marked decrease in antibacterial activity. These findings indicated that the presence of a hydroxyl group and the bulkiness of the C-6 substituent play an important role in the antimicrobial activity. Since the antimicrobial activity of all compounds against /Mactamase producing strains was comparable to that against non-producing strains, it is suggested that the presence of a hydroxyl group and the bulkiness of the C-6 substituent does not affect the susceptibility to /Mactamases so significant as to change its antimicrobial potency. The reduction of antimicrobial activity against P. aeruginosa was the most marked. The affinities for pseudomonal PBP-2 and PBP-3 of compound 2a were much lower than that of la. In addition, the affinities of compound 3a and 4a for all PBPs were markedly decreased. Thus, the lipophilicity and the bulkiness of C-6substituentobviously affect its interaction with pseudomonal PBPs. Theweakened affinities for the targets maypotentiallyreduce the anti-pseudomonal activity, although alteration of the OMpermeability may alsocontribute to the decrease of the anti-pseudomonal activity. Compounds 2a and3a, which do not possessa hydroxyl group on C-8, were unstable to DHP-L On the other hand, introduction of an additional methylgroup to the C-6substituentimproved the stability against DHP-I, comparing2a with 3a, andla with 4a. These findings suggestthatboth hydrophilicityand steric bulkiness of the C-6substituentincrease its resistance to DHP-I. Similarresults were obtained with other series of compounds having a piperidinylthiogroup (lb~4b)and an 7V-acetyl piperidinylthio group (lc~4c)at the C-2 position regarding both the antimicrobial activityand DHP-I stability. Amongthe three types of compounds having the same C-6substituent, the compounds having a DMAP group at C-2generally showed the best antimicrobial activity. Since the C-6substituentgreatly Abbreviations: See a footnote in Table 1 . n.t., not tested. * 6-lactamase producing strain H.^winp rpiativp T i_ir> affected the antimicrobial activity and the DHP-I stability in the same way irrespective of the C-2 side chain, further study was conducted using compounds having a DMAP group at C-2 ( Table 2 ).
The dehydrated derivative 5a showed lower antimicrobial activity against all organisms tested and lower stability against DHP-I than la. This observation supports that not only hydrophilicity but also stereochemistry of the C-6 substituent are important to maintain antimicrobial activity. To clarify the effect of lipophilicity and bulkiness of the C-6 substituent, 6-(l-hydroxy)phenylmethyl compound 6a and 6-(lhydroxy)propyl compounds7a and 8a were evaluated. Although compound6a was a mixture of diastereomers at C-8 (R: S=35 : 6), 6a revealed a significant reduction in the activity against all tested strains and affinities for pseudomonal PBPs, and showed high resistance against DHP-I. The antimicrobial activity of7a was also weaker than that of la but the degree of decrease was not so significant as that of 6a. These findings show that the bulkiness and/or increased lipophilicity of C-6 substituent result in a decrease in the antimicrobial activity. The bulkiness and/or lipophilicity of C-6 substituent may also affect theaffinities forpseudomonalPBPsand the stability against DHP-I, although thesedata of 7a and 8a could not be determineddue to shortageof thesamples forexaminations. In the case of the(l-hydroxy)propyl substituent, a comparison of theantimicrobialactivity between7a and its diastereomer 8a was attempted. Compound 8a (8-5" configuration) was less activethan 7a (8-jRconfiguration) in agreement with previousfindingsonthe stereochemical propertyof 6-hydroxyethyl group12'240.
Toinvestigate theeffect of introducing a basicor acidic propertyinto theC-6 substituent, weevaluated compound 9a and 10a, respectively (Table 2) . Although both compounds showed markedly decreased activity against most organisms,the pattern in theantimicrobial activity against P. aeruginosaand Haemophilus influenzae of thesecompounds were quite different. In spite of &-Sconfiguration, the antimicrobialactivity of 9a against P. aeruginosawas as high as that of la, whiletheactivity against H. influenzae was unusually weak. In contrast, 8-sulfonated compounds 10a showed decreased activity especially against P. aeruginosa. Mastalerz et aLxl) similarly reportedthat carbapenem having a 6-amino-ethyl group showed higher activity against P. aeruginosa than the corresponding 6-hydroxyethyl derivative. Since 9a had significantly lowered affinities for pseudomonal PBPs than la, the basic C-6 substituent contributes to the improvement of the permeability through the pseudomonal OMsimilarly to basicity in the C-2 side chain5). As for DHP-I stability, the two compounds again showed exactly opposite stabilities. Compound9a was more unstable to DHP-Ithan la, while 10a was extremely stable. Thus, basic C-6 substituent seems not to be preferred for DHP-I resistance and for antimicrobial activity except against P. aeruginosa. On the other hand, acidic substituent seems to be favorable to DHP-I resistance but not anti-pseudomonal activity, although the effect of bulkiness of sulfonyl group should be considered.
It was predicted that the di-substitution at C-6 position led to inferior antimicrobial activity, since the cis-configuration was knownto be inappropriate12) and the bulkiness around the C-6 substituent would have an undesirable effect on the activity as described above. The 6,6-dimethyl carbapenem (lla), as predicted, showed only weak antimicrobial activity against all the tested strains (> 12.5/xg/ml) and showed undetectable antipseudomonal activity ( > 200^g/ml) and affinities (IC5Os)
for PBPs (> 10/xg/ml). In contrast, the stability of lla against DHP-I was the same as that of la (relative T8Oo/o=1.0). It is consistent with the finding that desacetyl-epithienamycin A (ds-configuration) showed almost the same susceptibility to DHP-I as thienamycin25).
Amongthe tested carbapenems, the 6-hydroxyethyl group showed the best antimicrobial activity. Finally, we examined how muchthis group contributes to the antimicrobial activity and stability against DHP-I. 6-Nor compound 12a as well as 2-nor compound Id were examined to compare with the effect of the C-6 substituent and the C-2 side chain on the biological properties. Compound 12a showedalmost the sameantimicrobial activity as la including against P. aeruginosa, and the anti-pseudomonal activity of 12a was supported by the high affinities for the PBPs. However, the activity against /Mactamase producing strains of 12a was lower than that against non-/Mactamase producing strains except for Enterobacter cloacae. It is consistent with our previous report that 12a was hydrolyzed by some /Mactamases but not by a cephalosporinase from E. cloacae26). Since DHP-I stability of 12a was just slightly lower than that of la, it was found that the 6-hydroxyethyl group did not improve the DHP-I sta- JULY 1997 bility, significantly. Consequently, the 6-hydroxyethyl group is important primarily for acquiring resistance to the /Mactamases. In contrast, the 2-nor compound Id showed much lower antibacterial activity and DHP-I stability than those of la. The reason why Id showed low antimicrobial activity is not unclear, because the affinities of Id for PBPs were not determined. However, optimization of the C-2 side chain is important in improving both antimicrobial activity and DHP-I stability.
In summary, we found the structural features of the C-6 substituent affecting the antimicrobial activity and DHP-I stability and clarified the role of the C-6 substituent. The 6-(R) hydroxyethyl group was optimal to maintain both antimicrobial activity and DHP-I stability amongtested carbapenems and contributed to acquiring only the resistance for /Mactamases. This finding differs from the role of the C-2 side chain in relating strongly to biological properties of carbapenem antibiotics.
